FABP4 and obesity due to melanocortin 4 receptor deficiency: It has also been reported that elevated serum FABP4 concentration is associated with obesity, insulin resistance, type 2 diabetes mellitus, hypertension, cardiac dysfunction, renal dysfunction, dyslipidemia, atherosclerosis and cardiovascular events [8, 13–23].